2020
DOI: 10.1007/s12020-020-02389-z
|View full text |Cite
|
Sign up to set email alerts
|

Thioredoxin-1 attenuates atherosclerosis development through inhibiting NLRP3 inflammasome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
13
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 18 publications
(16 citation statements)
references
References 29 publications
2
13
0
Order By: Relevance
“…Namely, in MO-GMCSF cells, we identified strong enrichment of pathways associated with oxidative signaling consistent with emerging models relating metabolism in driving macrophage state (Cameron et al, 2019;West et al, 2011). We speculate that this interplay between oxidative signaling and metabolic state influence a multitude of macrophage functions, such as bacterial clearance and atherosclerosis, in vivo (Di Gioia et al, 2020;Huang et al, 2018;Wang et al, 2020). We identified and validated several novel markers of macrophage state.…”
Section: Gm-csf Mediates a Durable Switch In Il-10 Productionsupporting
confidence: 77%
“…Namely, in MO-GMCSF cells, we identified strong enrichment of pathways associated with oxidative signaling consistent with emerging models relating metabolism in driving macrophage state (Cameron et al, 2019;West et al, 2011). We speculate that this interplay between oxidative signaling and metabolic state influence a multitude of macrophage functions, such as bacterial clearance and atherosclerosis, in vivo (Di Gioia et al, 2020;Huang et al, 2018;Wang et al, 2020). We identified and validated several novel markers of macrophage state.…”
Section: Gm-csf Mediates a Durable Switch In Il-10 Productionsupporting
confidence: 77%
“…In atherosclerosis, macrophages play a central role in the initiation, growth, and final rupture of arterial plaque. Various studies based on different purposes have fully proved the vital role of macrophage inflammasome activation in the pathogenesis of atherosclerosis ( Tang et al, 2019 ; Yin et al, 2019 ; Tian et al, 2020 ; Wang et al, 2020 ). NLRP3 inflammasome activation is considered to be a key catalyst for atherogenesis.…”
Section: Introductionmentioning
confidence: 99%
“…Combating NLRP3 inflammasome activation by thioredoxin-1 significantly mitigates ROS-stimulating NLRP3 generation, IL-1β secretion and gets atherosclerosis stunted, unfolding atheroprotective functions. 127 Some other tactics of indirect or direct depressing NLRP3 inflammasome have been demonstrated to block inflammasome activation for diminished IL-1β with selectivity and advantage, embodying small-molecule inhibitors (MCC950, 128 β-hydroxybutyrate, arglabin) and microRNA(microRNA-223, suppressing NLRP3 protein expression), 129 and more inhibitors also had been summarized by Zahid and their colleagues. 130 The new therapeutic strategies inhibiting NLRP3 inflammasome activation are burgeoning.…”
Section: Aiming At Critical Pathological Proceedingmentioning
confidence: 99%